Hideaki Bando Selected Research

Creatinine

4/2019	Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
7/2016	Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Bando Research Topics

Disease

61	Neoplasms (Cancer) 04/2024 - 06/2009
49	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 06/2009
23	Stomach Neoplasms (Stomach Cancer) 10/2023 - 06/2015
8	Neoplasm Metastasis (Metastasis) 03/2024 - 06/2009
6	Neutropenia 12/2021 - 01/2016
5	Disease Progression 04/2024 - 01/2020
5	Adenocarcinoma 10/2023 - 01/2018
5	Esophageal Squamous Cell Carcinoma 01/2023 - 07/2016
4	Rectal Neoplasms (Rectal Cancer) 03/2024 - 08/2020
4	Microsatellite Instability 01/2024 - 11/2018
4	Febrile Neutropenia 12/2021 - 07/2016
4	Esophageal Neoplasms (Esophageal Cancer) 02/2021 - 10/2019
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 12/2020
3	Ascites 01/2021 - 06/2009
3	Diarrhea 11/2020 - 04/2019
2	Carcinoma (Carcinomatosis) 01/2024 - 07/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 09/2012
2	Vomiting 04/2019 - 05/2016
2	Hemorrhage 01/2018 - 12/2012
2	Lung Neoplasms (Lung Cancer) 01/2018 - 02/2012
2	Hyperglycemia 05/2016 - 08/2015
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Residual Neoplasm 01/2024
1	Dermatitis 01/2024
1	Burns 01/2024
1	Hyperphosphatemia 02/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Pathologic Complete Response 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2015
13	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2023 - 12/2012
11	Circulating Tumor DNAIBA 04/2024 - 01/2018
11	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2011
10	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 06/2009
9	NivolumabIBA 02/2024 - 01/2019
9	Fluorouracil (Carac)FDA LinkGeneric 03/2023 - 09/2012
8	Cetuximab (Erbitux)FDA Link 03/2024 - 06/2009
8	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2011
7	Bevacizumab (Avastin)FDA Link 03/2023 - 12/2012
7	AntibodiesIBA 01/2022 - 01/2011
6	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2020
6	Monoclonal AntibodiesIBA 01/2024 - 11/2017
6	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2016
5	RamucirumabIBA 07/2022 - 01/2018
4	Leucovorin (Folinic Acid)FDA Link 03/2023 - 12/2012
4	trifluridine tipiracil drug combinationIBA 12/2019 - 01/2016
4	S-1 plus cisplatinIBA 01/2019 - 01/2016
3	Cell-Free Nucleic AcidsIBA 03/2024 - 07/2017
3	binimetinibIBA 03/2024 - 01/2020
3	encorafenibIBA 03/2024 - 01/2020
3	regorafenibIBA 02/2024 - 12/2016
3	Phosphotransferases (Kinase)IBA 05/2023 - 07/2017
3	pembrolizumabIBA 01/2022 - 01/2019
3	ParaffinIBA 01/2022 - 01/2011
3	Formaldehyde (Formol)FDA Link 01/2022 - 01/2011
3	Capecitabine (Xeloda)FDA Link 12/2021 - 03/2017
3	Codon (Codons)IBA 09/2013 - 11/2012
2	Epidermal Growth Factor (EGF)IBA 04/2024 - 12/2012
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2023 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2022
2	LigandsIBA 01/2022 - 01/2022
2	napabucasinIBA 11/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 02/2021 - 07/2016
2	SteroidsIBA 11/2020 - 05/2016
2	CreatinineIBA 04/2019 - 07/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	Insulin (Novolin)FDA Link 05/2016 - 08/2015
1	Hormones (Hormone)IBA 04/2024
1	abemaciclibIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Trinitrotoluene (TNT)IBA 03/2024
1	TAS-116IBA 02/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	trastuzumab deruxtecanIBA 01/2024
1	shiunkoIBA 01/2024
1	Taxoids (Taxanes)IBA 06/2023
1	Mitogen-Activated Protein KinasesIBA 05/2023
1	futibatinibIBA 02/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2023
1	PlatinumIBA 01/2023
1	pertuzumabIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	ProteomeIBA 12/2022
1	niraparibIBA 12/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	lenvatinibIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

39	Therapeutics 04/2024 - 09/2012
27	Drug Therapy (Chemotherapy) 03/2024 - 06/2009
10	Chemoradiotherapy 03/2024 - 09/2012
8	Precision Medicine 03/2024 - 02/2016
4	Immunotherapy 02/2024 - 04/2020
4	Adjuvant Chemotherapy 01/2023 - 03/2017
2	Genomic Medicine 11/2022 - 09/2018
2	Induction Chemotherapy 02/2021 - 07/2016
2	Gastrectomy 02/2019 - 03/2017
1	Neoadjuvant Therapy 03/2024
1	Radiotherapy 03/2024
1	Proctectomy 01/2023